Lincoln SJ - Search Results

1

Genomewide association, Parkinson disease, and PARK10.

Farrer MJ, Haugarvoll K, Ross OA, Stone JT, Milkovic NM, Cobb SA, Whittle AJ, Lincoln SJ, Hulihan MM, Heckman MG, White LR, Aasly JO, Gibson JM, Gosal D, Lynch T, Wszolek ZK, Uitti RJ, Toft M. Farrer MJ, et al. Among authors: lincoln sj. Am J Hum Genet. 2006 Jun;78(6):1084-8; author reply 1092-4. doi: 10.1086/504728. Am J Hum Genet. 2006. PMID: 16685661 Free PMC article. No abstract available.

2

Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD).

Vaughan JR, Farrer MJ, Wszolek ZK, Gasser T, Durr A, Agid Y, Bonifati V, DeMichele G, Volpe G, Lincoln S, Breteler M, Meco G, Brice A, Marsden CD, Hardy J, Wood NW. Vaughan JR, et al. Hum Mol Genet. 1998 Apr;7(4):751-3. doi: 10.1093/hmg/7.4.751. Hum Mol Genet. 1998. PMID: 9499430

3

A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor.

Farrer M, Gwinn-Hardy K, Muenter M, DeVrieze FW, Crook R, Perez-Tur J, Lincoln S, Maraganore D, Adler C, Newman S, MacElwee K, McCarthy P, Miller C, Waters C, Hardy J. Farrer M, et al. Hum Mol Genet. 1999 Jan;8(1):81-5. doi: 10.1093/hmg/8.1.81. Hum Mol Genet. 1999. PMID: 9887334

4

No pathogenic mutations in the persyn gene in Parkinson's disease.

Lincoln S, Gwinn-Hardy K, Goudreau J, Chartier-Harlin MC, Baker M, Mouroux V, Richard F, Destée A, Becquet E, Amouyel P, Lynch T, Hardy J, Farrer M. Lincoln S, et al. Neurosci Lett. 1999 Jan 4;259(1):65-6. doi: 10.1016/s0304-3940(98)00901-x. Neurosci Lett. 1999. PMID: 10027558

5

Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.

Lincoln S, Vaughan J, Wood N, Baker M, Adamson J, Gwinn-Hardy K, Lynch T, Hardy J, Farrer M. Lincoln S, et al. Neuroreport. 1999 Feb 5;10(2):427-9. doi: 10.1097/00001756-199902050-00040. Neuroreport. 1999. PMID: 10203348

6

Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.

Maraganore DM, Farrer MJ, Hardy JA, Lincoln SJ, McDonnell SK, Rocca WA. Maraganore DM, et al. Among authors: lincoln sj. Neurology. 1999 Nov 10;53(8):1858-60. doi: 10.1212/wnl.53.8.1858. Neurology. 1999. PMID: 10563640

7

A kindred with Parkinson's disease not showing genetic linkage to established loci.

Gwinn-Hardy KA, Crook R, Lincoln S, Adler CH, Caviness JN, Hardy J, Farrer M. Gwinn-Hardy KA, et al. Neurology. 2000 Jan 25;54(2):504-7. doi: 10.1212/wnl.54.2.504. Neurology. 2000. PMID: 10668726

8

Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes.

West AB, Zimprich A, Lockhart PJ, Farrer M, Singleton A, Holtom B, Lincoln S, Hofer A, Hill L, Müller-Myhsok B, Wszolek ZK, Hardy J, Gasser T. West AB, et al. Eur J Hum Genet. 2001 Sep;9(9):659-66. doi: 10.1038/sj.ejhg.5200698. Eur J Hum Genet. 2001. PMID: 11571553

9

The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3.

Lockhart PJ, Holtom B, Lincoln S, Hussey J, Zimprich A, Gasser T, Wszolek ZK, Hardy J, Farrer MJ. Lockhart PJ, et al. Gene. 2002 Feb 20;285(1-2):229-37. doi: 10.1016/s0378-1119(02)00402-x. Gene. 2002. PMID: 12039050

10

Parkin-proven disease: common founders but divergent phenotypes.

Lincoln S, Wiley J, Lynch T, Langston JW, Chen R, Lang A, Rogaeva E, Sa DS, Munhoz RP, Harris J, Marder K, Klein C, Bisceglio G, Hussey J, West A, Hulihan M, Hardy J, Farrer M. Lincoln S, et al. Neurology. 2003 May 27;60(10):1605-10. doi: 10.1212/01.wnl.0000064289.49410.a9. Neurology. 2003. PMID: 12771249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page